Legal & General Group’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1K | Sell |
3,744
-27,674
| -88% | -$148K | ﹤0.01% | 3004 |
|
|
2025
Q1 | $168K | Hold |
31,418
| – | – | ﹤0.01% | 2629 |
|
|
2024
Q4 | $281K | Buy |
31,418
+2,222
| +8% | +$19.9K | ﹤0.01% | 2618 |
|
|
2024
Q3 | $321K | Buy |
29,196
+20,142
| +222% | +$222K | ﹤0.01% | 2596 |
|
|
2024
Q2 | $82.4K | Buy |
9,054
+3,996
| +79% | +$36.4K | ﹤0.01% | 2740 |
|
|
2024
Q1 | $71.2K | Buy |
5,058
+1,566
| +45% | +$22K | ﹤0.01% | 2755 |
|
|
2023
Q4 | $26.8K | Buy |
3,492
+894
| +34% | +$6.87K | ﹤0.01% | 2924 |
|
|
2023
Q3 | $19.4K | Sell |
2,598
-421
| -14% | -$3.15K | ﹤0.01% | 3042 |
|
|
2023
Q2 | $25.1K | Buy |
+3,019
| New | +$25.1K | ﹤0.01% | 3016 |
|
|
2021
Q2 | – | Sell |
-343
| Closed | -$6K | – | 3491 |
|
|
2021
Q1 | $6K | Hold |
343
| – | – | ﹤0.01% | 3458 |
|
|
2020
Q4 | $4K | Hold |
343
| – | – | ﹤0.01% | 3441 |
|
|
2020
Q3 | $13K | Sell |
343
-112
| -25% | -$4.25K | ﹤0.01% | 3117 |
|
|
2020
Q2 | $18K | Buy |
+455
| New | +$18K | ﹤0.01% | 3099 |
|